Trace amine-associated receptor 1 is a modulator of the dopamine transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 1, 2007, Pages 128-136

  Xie, Zhihua ^a   Miller, Gregory M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DOPAMINE; DOPAMINE TRANSPORTER; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; METHAMPHETAMINE; METHYLPHENIDATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TRACE AMINE ASSOCIATED RECEPTOR 1; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FORSKOLIN; HUMANS; INDOLES; LUCIFERASES; MACACA MULATTA; METHAMPHETAMINE; METHYLPHENIDATE; PHOSPHORYLATION; PROTEIN KINASE C; PYRROLES; RECEPTORS, G-PROTEIN-COUPLED; STIMULATION, CHEMICAL;

EID: 33947409843     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.117382     Document Type: Article

References (22)

1. Azzaro AJ and Rutledge CO (1973) Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain. Biochem Pharmacol 22:2801-2813.
2. Batchelor M and Schenk JO (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci 18:10304-10309.
3. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, et al. (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:8966-8971.
4. Branchek TA and Blackburn TP (2003) Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3:90-97.
5. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, et al. (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181-1188.
6. Eshleman AJ, Henningsen RA, Neve KA, and Janowsky A (1994) Release of dopamine via the human transporter. Mol Pharmacol 45:312-316.
7. Fischer JF and Cho AK (1979) Chem release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209.
8. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, and Hanson GR (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834-838.
9. Garris PA, Ciolkowski EL, Pastore P, and Wightman RM (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14:6084-6093.
10. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK, and Scanlan TS (2006) Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J Med Chem 49:1101-1112.
11. 3H]Substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux. Synapse 30:97-106.
12. Kitayama S, Dohi T, and Uhl GR (1994) Phorbol esters alter functions of the expressed dopamine transporter. Eur J Pharmacol 268:115-119.
13. Liang NY and Rutledge CO (1982) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 31:2479-2484.
14. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, and Madras BK (2005) Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313:983-994.
15. Sandoval V, Riddle EL, Ugarte YV, Hanson GR, and Fleckenstein AE (2001) Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 21:1413-1419.
16. Sulzer D, Sonders MS, Poulsen NW, and Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406-433.
17. Trogadis JE, Ng GY, O'Dowd BF, George SR, and Stevens JK (1995) Dopamine D1 receptor distribution in Sf9 cells imaged by confocal microscopy: a quantitative evaluation. J Histochem Cytochem 43:497-506.
18. Uhl GR and Johnson PS (1994) Neurotransmitter transporters: three important gene families for neuronal function. J Exp Biol 196:229-236.
19. Wainscott DB, Little SP, Yin T, Tu Y, Rocco VP, He JX, and Nelson DL (2007) Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. J Pharmacol Exp Ther 320:475-485.
20. Wall SC, Gu H, and Rudnick G (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol Pharmacol 47:544-550.
21. Xie Z, Bhushan RG, Daniels DJ, and Portoghese PS (2005) Interaction of bivalent ligand KDN21 with heterodimeric δ-κ opioid receptors in human embryonic kidney 293 cells. Mol Pharmacol 68:1079-1086.
22. Xie Z, Westmoreland S, Bahn ME, Chen G-L, Yang H, Vallender E, Yao W-D, Madras B-K, and Miller GM (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321:116-127.